UBS Group’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.2K | Sell |
|
|||||
|
2025
Q2 | $581K | Buy |
|
|||||
|
2025
Q1 | $170K | Buy |
|
|||||
|
2024
Q4 | $279K | Buy |
|
|||||
|
2024
Q3 | $96.3K | Buy |
|
|||||
|
2024
Q2 | $74K | Buy |
|
|||||
|
2024
Q1 | $15.1K | Buy |
|
|||||
|
2023
Q4 | $8.3K | Buy |
|
|||||
|
2023
Q3 | $2.85K | Buy |
|
|||||
|
2023
Q2 | $2.75K | Sell |
|
|||||
|
2023
Q1 | $6.8K | Buy |
|
|||||
|
2022
Q4 | $1.55K | Sell |
|
|||||
|
2022
Q3 | $11K | Buy |
|
|||||
|
2022
Q2 | $4K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $4K | Sell |
|
|||||
|
2021
Q3 | $8K | Buy |
|